A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Clinical trial NCT05648214 · RECRUITING
Trial details
- NCT number
- NCT05648214
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-27
- Primary completion
- 2027-08-10
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.